Pharma Payments Might Influence MS Drug Prescriptions, Researchers Argue

Key Takeaways

Most neurologists treating multiple sclerosis have receive payments from pharma firms

Those who prescribe high volumes of drugs are more likely to have received industry payments

Docs who got payments from a company were more likely to prescribe its drugs

THURSDAY, Sept. 18, 2025 (HealthDay News) — Nearly 4 out of 5 American neurologists prescribing multiple sclerosis (MS) drugs have received at least one payment from the pharmaceutical industry, a new study reports.

Those who prescribe larger amounts of MS drugs were more likely to have received payments, and those who got payments were more likely to prescribe the company’s drugs, especially if the payments were larger, sustained and recent, according to findings in BMJ Open .

The findings “raise concerns about ex